Literature DB >> 30295728

DIGREM: an integrated web-based platform for detecting effective multi-drug combinations.

Minzhe Zhang1, Sangin Lee2, Bo Yao1, Guanghua Xiao1,3, Lin Xu1,4, Yang Xie1,3.   

Abstract

MOTIVATION: Synergistic drug combinations are a promising approach to achieve a desirable therapeutic effect in complex diseases through the multi-target mechanism. However, in vivo screening of all possible multi-drug combinations remains cost-prohibitive. An effective and robust computational model to predict drug synergy in silico will greatly facilitate this process.
RESULTS: We developed DIGREM (Drug-Induced Genomic Response models for identification of Effective Multi-drug combinations), an online tool kit that can effectively predict drug synergy. DIGREM integrates DIGRE, IUPUI_CCBB, gene set-based and correlation-based models for users to predict synergistic drug combinations with dose-response information and drug-treated gene expression profiles.
AVAILABILITY AND IMPLEMENTATION: http://lce.biohpc.swmed.edu/drugcombination. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30295728      PMCID: PMC6513155          DOI: 10.1093/bioinformatics/bty860

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  15 in total

Review 1.  Mechanisms of drug combinations: interaction and network perspectives.

Authors:  Jia Jia; Feng Zhu; Xiaohua Ma; Zhiwei Cao; Zhiwei W Cao; Yixue Li; Yixue X Li; Yu Zong Chen
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694

Review 2.  Molecularly targeted cancer therapy: some lessons from the past decade.

Authors:  Min Huang; Aijun Shen; Jian Ding; Meiyu Geng
Journal:  Trends Pharmacol Sci       Date:  2013-12-19       Impact factor: 14.819

Review 3.  Combinatorial drug therapy for cancer in the post-genomic era.

Authors:  Bissan Al-Lazikani; Udai Banerji; Paul Workman
Journal:  Nat Biotechnol       Date:  2012-07-10       Impact factor: 54.908

4.  A community computational challenge to predict the activity of pairs of compounds.

Authors:  Mukesh Bansal; Jichen Yang; Charles Karan; Michael P Menden; James C Costello; Hao Tang; Guanghua Xiao; Yajuan Li; Jeffrey Allen; Rui Zhong; Beibei Chen; Minsoo Kim; Tao Wang; Laura M Heiser; Ronald Realubit; Michela Mattioli; Mariano J Alvarez; Yao Shen; Daniel Gallahan; Dinah Singer; Julio Saez-Rodriguez; Yang Xie; Gustavo Stolovitzky; Andrea Califano
Journal:  Nat Biotechnol       Date:  2014-11-17       Impact factor: 54.908

5.  A mathematical model of combination therapy using the EGFR signaling network.

Authors:  R P Araujo; E F Petricoin; L A Liotta
Journal:  Biosystems       Date:  2005-04       Impact factor: 1.973

6.  Partial Correlation Estimation by Joint Sparse Regression Models.

Authors:  Jie Peng; Pei Wang; Nengfeng Zhou; Ji Zhu
Journal:  J Am Stat Assoc       Date:  2009-06-01       Impact factor: 5.033

Review 7.  Cancer drug resistance: an evolving paradigm.

Authors:  Caitriona Holohan; Sandra Van Schaeybroeck; Daniel B Longley; Patrick G Johnston
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

8.  Prediction of drug combinations by integrating molecular and pharmacological data.

Authors:  Xing-Ming Zhao; Murat Iskar; Georg Zeller; Michael Kuhn; Vera van Noort; Peer Bork
Journal:  PLoS Comput Biol       Date:  2011-12-29       Impact factor: 4.475

9.  Predicting cooperative drug effects through the quantitative cellular profiling of response to individual drugs.

Authors:  J Zhao; X-S Zhang; S Zhang
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-02-26

10.  DrugComboRanker: drug combination discovery based on target network analysis.

Authors:  Lei Huang; Fuhai Li; Jianting Sheng; Xiaofeng Xia; Jinwen Ma; Ming Zhan; Stephen T C Wong
Journal:  Bioinformatics       Date:  2014-06-15       Impact factor: 6.937

View more
  2 in total

Review 1.  Network Control Models With Personalized Genomics Data for Understanding Tumor Heterogeneity in Cancer.

Authors:  Jipeng Yan; Zhuo Hu; Zong-Wei Li; Shiren Sun; Wei-Feng Guo
Journal:  Front Oncol       Date:  2022-05-31       Impact factor: 5.738

2.  Network Patterns of Herbal Combinations in Traditional Chinese Clinical Prescriptions.

Authors:  Ning Wang; Ninglin Du; Yonghong Peng; Kuo Yang; Zixin Shu; Kai Chang; Di Wu; Jian Yu; Caiyan Jia; Yana Zhou; Xiaodong Li; Baoyan Liu; Zhuye Gao; Runshun Zhang; Xuezhong Zhou
Journal:  Front Pharmacol       Date:  2021-01-20       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.